CurvaFix was granted FDA 510(k) clearance for its next-generation CurvaFix Low Profile System, a percutaneous solution for fixation of pelvic fractures.
The CurvaFix Low Profile System is built to expand surgical options in challenging scenarios, including pathological bone, curved or narrow pelvic corridors, intersecting fixation pathways and cases where indwelling or adjacent hardware is present. The new system offers:
65% smaller head geometry for a lower-profile construct
Implants with increased compression capability
Extended implant lengths up to 210mm, enabling connection of intraosseous fixation pathways with a single device
Patented lock technology with improved visual and tactile confirmation
Clinical experience has shown that the CurvaFix technology provides strong, stable fixation that follows and fills the natural curvature of each patient’s anatomy. This unique approach may reduce pain, support earlier mobility and improve recovery compared to conventional straight implants.
“CurvaFix continues to revolutionize pelvic fracture fixation with the launch of our Low-Profile System,” said Mark Foster, CEO of CurvaFix. “This new system reflects four years of clinical use and thousands of successful implants, coupled with direct feedback from orthopedic trauma surgeons. The result is a familiar, intuitive implantation technique designed to address the complexities of pelvic fracture fixation, while also allowing streamlined implant removal if required.”
CurvaFix was granted FDA 510(k) clearance for its next-generation CurvaFix Low Profile System, a percutaneous solution for fixation of pelvic fractures.
The CurvaFix Low Profile System is built to expand surgical options in challenging scenarios, including pathological bone, curved or narrow pelvic corridors, intersecting fixation pathways and...
CurvaFix was granted FDA 510(k) clearance for its next-generation CurvaFix Low Profile System, a percutaneous solution for fixation of pelvic fractures.
The CurvaFix Low Profile System is built to expand surgical options in challenging scenarios, including pathological bone, curved or narrow pelvic corridors, intersecting fixation pathways and cases where indwelling or adjacent hardware is present. The new system offers:
65% smaller head geometry for a lower-profile construct
Implants with increased compression capability
Extended implant lengths up to 210mm, enabling connection of intraosseous fixation pathways with a single device
Patented lock technology with improved visual and tactile confirmation
Clinical experience has shown that the CurvaFix technology provides strong, stable fixation that follows and fills the natural curvature of each patient’s anatomy. This unique approach may reduce pain, support earlier mobility and improve recovery compared to conventional straight implants.
“CurvaFix continues to revolutionize pelvic fracture fixation with the launch of our Low-Profile System,” said Mark Foster, CEO of CurvaFix. “This new system reflects four years of clinical use and thousands of successful implants, coupled with direct feedback from orthopedic trauma surgeons. The result is a familiar, intuitive implantation technique designed to address the complexities of pelvic fracture fixation, while also allowing streamlined implant removal if required.”
Copy to clipboard 
